354 related articles for article (PubMed ID: 23312550)
1. TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma.
Odate S; Nakamura K; Onishi H; Kojima M; Uchiyama A; Nakano K; Kato M; Tanaka M; Katano M
Lung Cancer; 2013 Mar; 79(3):205-14. PubMed ID: 23312550
[TBL] [Abstract][Full Text] [Related]
2. Tropomyosin-related kinase B inhibitor has potential for tumor regression and relapse prevention in pulmonary large cell neuroendocrine carcinoma.
Odate S; Onishi H; Nakamura K; Kojima M; Uchiyama A; Kato M; Katano M
Anticancer Res; 2013 Sep; 33(9):3699-703. PubMed ID: 24023298
[TBL] [Abstract][Full Text] [Related]
3. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of BDNF suppressed invasion of HepG2 and HCCLM3 cells, a mechanism associated with inactivation of RhoA or Rac1 and actin skeleton disorganization.
Guo D; Sun W; Zhu L; Zhang H; Hou X; Liang J; Jiang X; Liu C
APMIS; 2012 Jun; 120(6):469-76. PubMed ID: 22583359
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
[TBL] [Abstract][Full Text] [Related]
6. Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer.
Kimura S; Harada T; Ijichi K; Tanaka K; Liu R; Shibahara D; Kawano Y; Otsubo K; Yoneshima Y; Iwama E; Nakanishi Y; Okamoto I
Lung Cancer; 2018 Jun; 120():98-107. PubMed ID: 29748024
[TBL] [Abstract][Full Text] [Related]
7. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.
Kawamoto M; Onishi H; Ozono K; Yamasaki A; Imaizumi A; Kamakura S; Nakano K; Oda Y; Sumimoto H; Nakamura M
Oncotarget; 2017 May; 8(22):36211-36224. PubMed ID: 28423707
[TBL] [Abstract][Full Text] [Related]
8. Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer.
Okamura K; Harada T; Wang S; Ijichi K; Furuyama K; Koga T; Okamoto T; Takayama K; Yano T; Nakanishi Y
Lung Cancer; 2012 Oct; 78(1):100-6. PubMed ID: 22906736
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
[TBL] [Abstract][Full Text] [Related]
10. Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas.
Nagashio R; Sato Y; Matsumoto T; Kageyama T; Satoh Y; Ryuge S; Masuda N; Jiang SX; Okayasu I
Pathol Int; 2010 Feb; 60(2):71-7. PubMed ID: 20398190
[TBL] [Abstract][Full Text] [Related]
11. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases.
Nagao T; Sugano I; Ishida Y; Tajima Y; Munakata S; Asoh A; Yamazaki K; Muto H; Konno A; Kondo Y; Nagao K
Mod Pathol; 2000 May; 13(5):554-61. PubMed ID: 10824928
[TBL] [Abstract][Full Text] [Related]
12. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
[TBL] [Abstract][Full Text] [Related]
13. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor promotes tumorigenesis via induction of neovascularization: implication in hepatocellular carcinoma.
Lam CT; Yang ZF; Lau CK; Tam KH; Fan ST; Poon RT
Clin Cancer Res; 2011 May; 17(10):3123-33. PubMed ID: 21421859
[TBL] [Abstract][Full Text] [Related]
15. Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and β-catenin phosphorylation and following transplantation into the developing brain.
Lim JY; Park SI; Kim SM; Jun JA; Oh JH; Ryu CH; Jeong CH; Park SH; Park SA; Oh W; Chang JW; Jeun SS
Cell Transplant; 2011; 20(11-12):1855-66. PubMed ID: 21375801
[TBL] [Abstract][Full Text] [Related]
16. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix.
Moon A; Won KY; Lee JY; Kang I; Lee SK; Lee J
Pathology; 2011 Aug; 43(5):453-8. PubMed ID: 21670725
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
Wang ZX; Lu BB; Yang JS; Wang KM; De W
J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
[TBL] [Abstract][Full Text] [Related]
18. TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer.
Oyama Y; Nagao S; Na L; Yanai K; Umebayashi M; Nakamura K; Nagai S; Fujimura A; Yamasaki A; Nakayama K; Morisaki T; Onishi H
Anticancer Res; 2021 Aug; 41(8):4047-4052. PubMed ID: 34281873
[TBL] [Abstract][Full Text] [Related]
19. Autocrine activity of BDNF induced by the STAT3 signaling pathway causes prolonged TrkB activation and promotes human non-small-cell lung cancer proliferation.
Chen B; Liang Y; He Z; An Y; Zhao W; Wu J
Sci Rep; 2016 Jul; 6():30404. PubMed ID: 27456333
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome.
Au CW; Siu MK; Liao X; Wong ES; Ngan HY; Tam KF; Chan DC; Chan QK; Cheung AN
Cancer Lett; 2009 Aug; 281(2):151-61. PubMed ID: 19307055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
